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Background: Fluorescent proteins are used widely as reporter genes in many organisms. We previously codon-optimized
mCherry for Mycobacterium tuberculosis and generated expression constructs with high level expression in mycobacteria
with multiple uses in vitro and in vivo. However, little is known about the expression of fluorescent proteins in
mycobacteria and the translational start codon for mCherry has not been experimentally determined.
Results: We determined the translational start site for functional (fluorescent) mCherry in mycobacteria. Several
potential translational start codons were identified; introduction of downstream stop codons by mutagenesis was
used to determine which start codon was utilized in the bacterial cells. Fluorescent protein was expressed from a
construct which would allow translation of a protein of 226 amino acids or a protein of 235 amino acids. No
fluorescence was seen when a construct which could give rise to a protein of 219 amino acids was used. Similar
results were obtained in mycobacteria and in Escherichia coli. Western blotting confirmed that mCherry was
expressed from the constructs encoding 235 or 226 amino acids, but not from the plasmid encoding 219 amino
acids. N-terminal sequencing and mass determination confirmed that the mature protein was 226 amino acids and
commenced with the amino acid sequence AIIKE.
Conclusion: We conclude that mCherry is expressed in M. tuberculosis as a smaller protein than expected lacking
the GFP-derived N-terminal sequence designed to allow efficient fusions.
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Fluorescent proteins (FPs), in particular GFP derivatives,
are widely used in mycobacterial systems for many
applications [1-13]. Numerous FP variants have been
developed, many of which are variants of the original green
fluorescent protein (GFP) from the jellyfish Aequorea
victoria [3,14], or the red fluorescent protein DsRed from
the coral Discosoma sp red [15,16]. The wide range of
FPs available have different features, including different
excitation and emission wavelengths, expression as mono-
mers or dimers, stability, susceptibility to photobleaching,
and responsiveness to environmental conditions such as
pH or redox [6,17-22].* Correspondence: tanya.parish@idri.org
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unless otherwise stated.We are interested in the use of FPs as reporters in
mycobacteria. We have previously generated FP variants
with codon usage optimized for Mycobacterium tuberculosis
[2,13]. We were able to generate plasmid expression
systems with high level constitutive expression that
resulted in highly fluorescent strains of use for both
in vitro and in vivo studies [2,13]. We investigated the
use of alternative promoters to generate the highest
level of expression possible, without inducing plasmid
instability or compromising bacterial growth or viru-
lence [2,13]. Such reporter strains are of use in multiple
applications, including gene expression studies [2], identi-
fying novel anti-tubercular agents [12,23,24] or monitor-
ing growth in vivo [13].
The level of expression of an FP is dependent on tran-
scriptional and translational factors, but in bacteria the
main factor is the promoter. The promoter location inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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can play a role in determining overall expression levels.
In our original constructs we used the translational start
site of the engineered protein mCherry from the litera-
ture in order to place the gene in the correct location
relative to the promoter. The original development of
mCherry involved replacing the first seven amino acids
to improve the ability to generate functional N-terminal
fusions, although the sequence still retained a downstream
methionine which could function as an alternative start
[17]. In order to generate further improved constructs
and to characterize the recombinant fluorescent protein
expressed in mycobacteria, we determined the functional
translational start site for mCherry. Our data demonstrate
that mCherry is expressed in M. tuberculosis as a truncated
protein which lacks the N-terminal sequence derived from
GFP (MVSKGEE).
Results and discussion
We are interested in the use of FPs as reporters of
bacterial viability and gene expression in mycobacteria, in
particular in M. tuberculosis [2,13]. The expression of FPs
at high level can be detrimental to bacterial viability due
to the metabolic burden it places on the cell. We have
developed codon-optimized FPs for M. tuberculosis to, at
least partly, overcome this by removing rare codons and
allowing for high level expression [2].
The functional translational start site for mCherry in
M. tuberculosis
We previously optimized expression of mCherry by
codon-optimization of the most commonly used variant
[2]. During our studies we noted that there were several
potential translational start sites. Three of these (including
the expected one) had a ribosome binding site (RBS) motif
directly upstream, suggesting that translation could initi-
ate in multiples places (Figure 1). Interestingly, the two in-
ternal RBS and the downstream start codons were present
in the original sequence and were not introduced by
codon optimization. The translational start site of DsRed,
from which mCherry is derived, has not been determined
functionally for the native protein [15]. In the original
studies the DsRed protein was expressed with a His-Tag
and the primary amino acid sequence was derived from
the sequence of the mRNA rather than protein sequen-
cing [15]. mCherry itself was constructed by replacing the
first seven amino acids of mRFP1.1 with the correspond-
ing GFP sequence and is thus a fusion protein. Therefore
it is possible that the functional protein is shorter than
that expected, or that different proteins could be produced
in different species depending on the efficiency of the RBS
and the translational machinery.
We decided to determine which of the alternative
translational start sites are functional in M. tuberculosis.We used an expression construct (pCherry10) in which
mCherry is under the control of the G13 promoter from
M. marinum [13]; this is a strong constitutive promoter.
There are three potential translational start sites at +1, +28
and +52 (relative to the expected start site); to determine
which of these was functioning in mycobacteria, we intro-
duced a stop codon either at +13 or at +40 (plasmids
pCherry29 and pCherry30). This would prevent translation
of full length protein from the +1 or +28 start sites re-
spectively and translation would results in proteins of 226
or 219 amino acids, instead of 235 in the “full length”
version.
Constructs were introduced into M. tuberculosis. We
already demonstrated that functional fluorescent pro-
tein was produced from the parental vector pCherry10
[13]. It was apparent immediately that functional FP
was made from one of the expression vectors, since the
colonies were visibly colored (Figure 2A); this was con-
firmed by measuring fluorescence in cells (Figure 2B).
No difference in fluorescence intensity was seen when
a stop codon was introduced upstream of the start
codon at +28, whereas a complete loss of fluorescence
was noted when a stop codon was introduced upstream
of the +52 start codon. These data confirm that func-
tional, fluorescent protein is obtained in M. tubercu-
losis from a truncated protein (mCherry226), but not
from mCherry219.
The same results were obtained in Escherichia coli (data
not shown), where fluorescence was seen with mCherry226,
but not mCherry219. This suggested that the functional
translational start site was the same in both species. In
order to determine if the lack of fluorescence was from lack
of expression or if the protein was produced, but not
functional, we looked at protein levels by Western
blotting. Expression of mCherry was seen from plasmid
pCherry10 and pCherry29, but not from pCherry30, sug-
gesting that the translational start site at +52 does not lead
to the production of protein (Figure 2C).
mCherry is expressed as a mature protein of 226
amino acids
The mutagenesis study suggested that mCherry could be
expressed as a functional 226 amino acid protein from
pCherry29, but did not exclude the possibility that it was
expressed as a longer protein form the pCherry10 plas-
mid. In order to address this, we purified mCherry from
an M. tuberculosis transformant carrying pCherry10. Mass
determination suggested that the protein had a size of
25612.2 Da, which closely approximated the predicted size
for the 226 amino acid protein of 25579.9 Da (Figure 3).
N-terminal sequencing confirmed that the purified protein
commenced with the amino acids AAIKE, confirming that
mCherry226 is the functional species of protein found in
mycobacteria.
Figure 1 Sequence of mCherry. (A) DNA sequence of codon-optimized mCherry gene. The potential translational start sites are indicated in
bold and underlined; potential ribosome-binding sites and the stop codon are underlined. The codons mutagenized to stop codons are in red
and boxed. (B) Protein sequence of mCherry indicating the four potential start sites in bold. The identified start site is underlined.
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We obtained high-level expression of mCherry from the
G13 promoter in M. tuberculosis. Analysis of the mature
protein expressed in M. tuberculosis confirmed that the
translational start site at +28 was utilized and the N-
terminal sequence of the mature protein was AIIKE.
The expression of truncated mCherry gave rise to highly
fluorescent colonies, confirming that this truncated protein
is functional. However, the absence of the GFP-derived




Figure 2 Identification of the translational start site of mCherry in M.
tuberculosis and transformants selected on solid medium using hygromycin
=mCherry226; pCherry30 =mCherry219; pCherry0 (control plasmid) = no mC
measured in liquid culture. Cultures were measured at Ex587/Em610 and re
Data are the mean and standard deviation from three independent transfo
extracts were generated from transformants carrying plasmids and probed
(mCherry235). Lane 3- pCherry29 (mCherry226). Lane 4- pCherry30 (mCherry2




Escherichia coli DH5α was cultured in LB medium or on
LA agar. M. tuberculosis H37Rv was grown in Middlebrook
7H9 medium plus 10% v/v OADC (oleic acid, albumen,
dextrose, catalase) supplement (Becton Dickinson) and
0.05% w/v Tween 80 or on Middlebrook 7H10 agar(C)
Cherry30




tuberculosis. Plasmids carrying mCherry were electroporated into M.
. The predicted proteins expressed from each plasmid are - pCherry29
herry expression. (A) Transformant colonies. (B) Fluorescence was
sults are expressed as relative fluorescence units (fluorescence/OD).
rmants (C) Western analysis of protein expression in E. coli. Cell-free
with anti-mCherry antibodies. Lane 1: no plasmid. Lane 2- pCherry10
19). A non-specific band reacting with the commercial antibody was
Figure 3 Purification and mass determination of mCherry. (A) 4-12% Bis-Tris SDS-PAGE gel of Q-sepharose purification. Lane 1 - cleared
cell-free extract; Lane 2- wash; Lane 3 - Benchmark ladder; Lane 4 to17 - gradient elutions. (B) 4-12% Bis-Tris SDS-PAGE of size exclusion purification. Lane
1- loaded protein; Lane 2 - Benchmark ladder; Lanes 3 to 17 - elution fractions. (C) ESI-MS ion envelope of purified mCherry protein, deconvolution
calculation, and primary sequence of mCherry protein based on observed mass and protein sequencing. Amino-acids detected from N-terminal
protein sequencing in bold, chromophore forming residues underlined, with the expected mass of the mature protein listed after the
primary sequence.
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was used at 100 μg/ml where required.
Construction of expression vectors
The mCherry expression vector pCherry10 was used as a
template for mutagenesis [13]. Site directed mutagenesis
was used to introduce a stop codon using primer pair
CherrySTOPA1 5′- TCC ATG GTC TCG AAG TGA
GAG GAG GAC AAC ATG-3′ and CherrySTOPA2 5′-
CAT GTT GTC CTC CTC TCA CTT CGA GAC CAT
GGA -3′ to generate pCherry29, or primer pair CherryS-
TOPB1 5′-GAC AAC ATG GCG ATC TGA AAG GAG
TTC ATG CGC-3′ and CherrySTOPB2 5′- GCG CAT
GAA CTC CTT TCA GAT CGC CAT GTT GTC-3′ to
generate pCherry30. Stop codons are in bold.
Quantitation of fluorescence in whole cells
M. tuberculosis was electroporated as described previ-
ously [25] and transformants selected with hygromycin.
E. coli and M. tuberculosis were grown to stationary
phase, harvested, washed twice in 10 mM Tris pH 8.0 and
resuspended in 10 mM Tris pH 8.0 to an OD580 of 0.25,
0.10, 0.05 and 0.01 in 12 × 100 mm glass culture tubes.
Fluorescence was measured on a Shimadzu RF-1501spectrofluorimeter (Shimadzu) with a detection range
of 0–1015 relative fluorescent units at the emission and
excitation wavelengths of 587/610 nm.
Western analysis of fluorescent proteins
Cell extracts were prepared from liquid cultures. Cells
were harvested by centrifugation, washed twice in 10 mM
Tris (pH 8.0), resuspended in 1 mL of 10 mM Tris
(pH 8.0), and added to lysing matrix B tubes (QBiogene).
Cells were disrupted using the Fastprep (QBiogene) set at
speed 6.0 for 30 seconds. Samples were centrifuged for
two min, and the supernatant was recovered and filter
sterilized. Protein was quantified using a BCA kit (Pierce),
and 10 μg of total protein was subjected to Western blot
using rabbit anti-mCherry antibody (Clontech). The pri-
mary antibody was detected using horseradish peroxidase
goat-anti-rabbit (Sigma), and activity was detected using
an ECL kit (GE Healthcare).
Mass determination and N-terminal sequencing of mCherry
Cell-free extracts were prepared from recombinant M.
tuberculosis carrying plasmid pCherry10, diluted 5 fold
into 20 mM Tris pH 8.0, 10 mM NaCl and loaded onto a
buffer equilibrated Q-sepharose column (GE Healthcare).
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20 mM Tris pH 8.0, 10 mM NaCl and mCherry protein
was eluted using a stepwise increase in salt concentration
up to 1 M NaCl. Eluted fractions were concentrated separ-
ately using Amicon Ultra Centrifugal Filters 10,000 MWCO
(Millipore), coloured fractions pooled, and concentrated to
100 μL. Protein was further purified by applying pooled
fractions to a Superdex 75 size-exclusion column (GE
Healthcare) and eluting with 20 mM Tris pH 8.0, 10 mM
NaCl buffer. Coloured fractions were pooled and concen-
trated to 25 μM (0.62 mg/mL). Protein was analyzed by
LC-ESI-MS by diluting 15 μL of concentrate into 15 μL
acetonitrile, 0.1% TFA, loading onto a Polaris 3 C8-A
150x4.6 mm column and eluting with an acetonitrile gradi-
ent over 30 min. Mass peaks from multiply charged species
were deconvoluted to yield the mass of the mCherry
protein. Edman degradation was carried out on 400
pmol of purified protein by Biosynthesis, Inc. on a Procise
II Protein Sequencing System (Applied Biosystems).
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